Ashland Inc. ASH, a specialty chemical company, is underperforming the market and experiencing earnings downgrades due to industry headwinds. Ashland Inc sales fell -15% YoY as customers de-stocked inventory due to macroeconomic uncertainty, while tight raw materials supply increased costs.
This challenging environment is showing up in earnings misses, a declining stock price, and earnings estimates that continue to roll over, giving ASH a Zacks Rank #5 (Strong Sell) rating.
Sales Sliding
Sales and earnings have been falling at Ashland for some time, and the stream of recent challenges it faces only exacerbate that trend. Annual sales have been steadily declining over the last ten years, dropping from $6.5 billion to $2.3 billion today. It looked like 2020 may have been the trough, though the current situation lends to the possibility of new lows for revenue.
That being said, EPS have not declined nearly as much as sales. Over the last ten years EPS has fallen from $6.00 to $5.09, indicating that they have significantly improved profitability even with the lower sales. Nonetheless, near-term challenges mean the stock should be avoided until there is a material improvement in earnings estimates.
Earnings Estimates Crater
Current quarter earnings estimates have been downgraded by -41% over the last two months and are expected to fall 29.4% YoY to $1.03. Additionally, FY23 estimates have been revised lower by -21% and are forecast to fall -18.3% YoY to $4.66 per share.
Sales are also projected to fall in the current quarter, next quarter and FY23, however they are expected to rebound in FY24 with a 5% YoY gain.
Valuation
ASH is trading at a one year forward earnings multiple of 18.2x, which is below the industry average of 22.9x, and below its five-year median. While this is a relatively fair valuation, falling sales growth and macroeconomic headwinds mean it is still too high.
Bottom Line
Ashland Inc. is by no means a business that I expect to disappear. The company provides goods for an array of industries, has a dividend payment it regularly increases, and steadily repurchases shares. However, in the near-term, falling earnings estimates and shifting economic trends make the situation far too uncertain to consider investing in the stock.
While I think there is a path where ASH turns the business around, now is not the time to expect that to materialize and thus investors should look for opportunities elsewhere in the market.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Ashland Inc. ASH, a specialty chemical company, is underperforming the market and experiencing earnings downgrades due to industry headwinds. Ashland Inc sales fell -15% YoY as customers de-stocked inventory due to macroeconomic uncertainty, while tight raw materials supply increased costs.
This challenging environment is showing up in earnings misses, a declining stock price, and earnings estimates that continue to roll over, giving ASH a Zacks Rank #5 (Strong Sell) rating.
Sales Sliding
Sales and earnings have been falling at Ashland for some time, and the stream of recent challenges it faces only exacerbate that trend. Annual sales have been steadily declining over the last ten years, dropping from $6.5 billion to $2.3 billion today. It looked like 2020 may have been the trough, though the current situation lends to the possibility of new lows for revenue.
That being said, EPS have not declined nearly as much as sales. Over the last ten years EPS has fallen from $6.00 to $5.09, indicating that they have significantly improved profitability even with the lower sales. Nonetheless, near-term challenges mean the stock should be avoided until there is a material improvement in earnings estimates.
Earnings Estimates Crater
Current quarter earnings estimates have been downgraded by -41% over the last two months and are expected to fall 29.4% YoY to $1.03. Additionally, FY23 estimates have been revised lower by -21% and are forecast to fall -18.3% YoY to $4.66 per share.
Sales are also projected to fall in the current quarter, next quarter and FY23, however they are expected to rebound in FY24 with a 5% YoY gain.
Valuation
ASH is trading at a one year forward earnings multiple of 18.2x, which is below the industry average of 22.9x, and below its five-year median. While this is a relatively fair valuation, falling sales growth and macroeconomic headwinds mean it is still too high.
Bottom Line
Ashland Inc. is by no means a business that I expect to disappear. The company provides goods for an array of industries, has a dividend payment it regularly increases, and steadily repurchases shares. However, in the near-term, falling earnings estimates and shifting economic trends make the situation far too uncertain to consider investing in the stock.
While I think there is a path where ASH turns the business around, now is not the time to expect that to materialize and thus investors should look for opportunities elsewhere in the market.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.2% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Get the latest research report on ASH - FREE